Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Completed
GlaxoSmithKline
Phase 4
2015-10-14
The purpose of this study is to assess the immunogenicity and safety of Boostrix™ when
compared to a placebo given during 27-36 weeks of gestation in healthy women aged 18-45
years. Infants born to mothers enrolled in this study will be followed-up in two separate
clinical studies: 201330 [DTPA (BOOSTRIX)-048 PRI] and 201334 [DTPA (BOOSTRIX)-049 BST: 048].
Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Completed
GlaxoSmithKline
Phase 4
2016-01-22
The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals'
Infanrix hexa, given in the primary vaccination schedule to infants born to pregnant women
who participated in study 116945 [DTPA (BOOSTRIX)-047]. This study will help us evaluate if
the presence of transplacentally transferred maternal antibodies interfere with the immune
response to primary vaccination with Infanrix hexa and a co-administered pneumococcal
conjugate vaccine given as a part of this study in infants.
Pertussis and Meningitis C Concomitant Vaccination in Adolescents
Completed
Public Health England
Phase 4
2013-09-01
The trial includes groups receiving various combinations of meningitis C and pertussis
containing vaccines, to be administered concomitantly in adolescents due their school leaving
booster vaccinations (as per UK routine immunisation schedule at 13-17 years of age).
Immunogenicity and reactogenicity will be assessed.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
